Below is Validea's guru fundamental report for ASCENDIS PHARMA A/S (ADR) (ASND). Of the 22 guru strategies we follow, ASND rates highest using our Small-Cap Growth Investor model based on the ...

Below is Validea's guru fundamental report for ASCENDIS PHARMA A/S (ADR) (ASND). Of the 22 guru strategies we follow, ASND rates highest using our Small-Cap Growth Investor model based on the ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

However, choosing the right payment gateway can be a challenge as pricing and transaction fees differ as do the features and inclusions. To help, Forbes Advisor has rounded up the best payment ...

The New English Bible was a translation undertaken by the major Protestant churches of the British Isles. Scholars translated from the best Hebrew and Greek texts, aiming to present the full meaning ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Short interest in Ascendis Pharma AS (NASDAQ:ASND) increased during the last reporting period, rising from 3.22M to 3.23M. This put 7.61% of the company's publicly available shares short.

In a report released yesterday, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Ascendis Pharma (ASND – Research Report), with a price target of $203.00. Tazeen Ahmad has ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...